{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:33:22Z","timestamp":1767598402463},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jacl.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T08:22:44Z","timestamp":1487924564000},"page":"543-550","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy"],"prefix":"10.1016","volume":"11","author":[{"given":"Ranganath","family":"Muniyappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent S.","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary F.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine K.","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica C.","family":"Skarulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Gorden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2017.02.002_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","article-title":"Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals","volume":"34","author":"Moon","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacl.2017.02.002_bib2","doi-asserted-by":"crossref","first-page":"E1676","DOI":"10.1210\/jc.2014-1878","article-title":"Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation of HDL-C and triglycerides","volume":"99","author":"Joseph","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.02.002_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0b013e32832d4a33","article-title":"Inherited lipodystrophies and hypertriglyceridemia","volume":"20","author":"Simha","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2017.02.002_bib4","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Diker-Cohen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.02.002_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4158\/EP11229.OR","article-title":"Clinical effects of long-term metreleptin treatment in patients with lipodystrophy","volume":"17","author":"Chan","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacl.2017.02.002_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2017.02.002_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2017.02.002_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tem.2013.12.005","article-title":"Regulation of lipoprotein lipase by Angptl4","volume":"25","author":"Dijk","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.02.002_bib9","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","article-title":"Transgenic angiopoietin-like (Angptl)4 overexpression and targeted disruption of Angptl4 and Angptl3: regulation of triglyceride metabolism","volume":"146","author":"Koster","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacl.2017.02.002_bib10","doi-asserted-by":"crossref","first-page":"E1299","DOI":"10.1210\/jc.2015-1254","article-title":"Regulation of angiopoietin-like proteins (ANGPTLs) 3 and 8 by insulin","volume":"100","author":"Nidhina Haridas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.02.002_bib11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbrc.2008.12.018","article-title":"Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis","volume":"379","author":"Adachi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacl.2017.02.002_bib12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1194\/jlr.M300031-JLR200","article-title":"A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice","volume":"44","author":"Ando","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2017.02.002_bib13","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2017.02.002_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2017.02.002_bib15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2004.08.024","article-title":"Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor","volume":"322","author":"Shimamura","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacl.2017.02.002_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Mari","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2017.02.002_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/s-2007-1010891","article-title":"Lipid metabolism in lipoatrophic diabetes","volume":"20","author":"Enzi","year":"1988","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jacl.2017.02.002_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MOL.0000000000000290","article-title":"Regulation of lipid metabolism by angiopoietin-like proteins","volume":"27","author":"Dijk","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2017.02.002_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.2004.02103.x","article-title":"Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons","volume":"61","author":"Wajchenberg","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jacl.2017.02.002_bib20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1194\/jlr.M500005-JLR200","article-title":"Differential regulation and properties of\u00a0angiopoietin-like proteins 3 and 4","volume":"46","author":"Ge","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2017.02.002_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1194\/jlr.M200367-JLR200","article-title":"Regulation of the angiopoietin-like protein 3 gene by LXR","volume":"44","author":"Kaplan","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2017.02.002_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/ATVBAHA.113.302802","article-title":"Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits","volume":"34","author":"Mehta","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2017.02.002_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jacl.2016.06.005","article-title":"JCL roundtable: diagnosis and clinical management of lipodystrophy","volume":"10","author":"Brown","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.02.002_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2337\/dc13-2040","article-title":"Effects of leptin replacement therapy on pancreatic beta-cell function in patients with lipodystrophy","volume":"37","author":"Muniyappa","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2017.02.002_bib25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.M002618","article-title":"Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample","volume":"51","author":"Robciuc","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2017.02.002_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-015-0324-y","article-title":"Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study","volume":"15","author":"Chung","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacl.2017.02.002_bib27","doi-asserted-by":"crossref","first-page":"e0133640","DOI":"10.1371\/journal.pone.0133640","article-title":"Circulating betatrophin correlates with triglycerides and postprandial glucose among different glucose tolerance statuses\u2013a case-control study","volume":"10","author":"Gao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2017.02.002_bib28","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/MCB.20.14.5343-5349.2000","article-title":"Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation","volume":"20","author":"Yoon","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jacl.2017.02.002_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1479164110369848","article-title":"Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob\/ob mouse","volume":"7","author":"Imran","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacl.2017.02.002_bib30","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1210\/jc.2015-3891","article-title":"Effect of leptin administration on circulating apolipoprotein CIII levels in patients with lipodystrophy","volume":"101","author":"Kassai","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.02.002_bib31","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.atherosclerosis.2015.04.115","article-title":"ISIS-ANGPTL3RX, an antisense inhibitor to angiopoietin-like 3, reduces plasma lipid levels in mouse models and in healthy human volunteers","volume":"241","author":"Brandt","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417300284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417300284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T02:53:35Z","timestamp":1536029615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287417300284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1933287417300284"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2017.02.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}